Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases

被引：0
|
作者：
Zhenhong Wang
Jian An
Chaohua Wang
机构：
[1] Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics,Department of Gynecology
[2] Fujian Medical University,Department of Gynecology, Women and Children’s Hospital, School of Medicine
[3] Xiamen University,Department of Gynecology and Obstetrics
[4] Peking University People’s Hospital,undefined
来源：
BMC Women's Health | / 22卷
关键词：
Chemotherapy; Premature ovarian failure; Perimenopausal symptoms; Myeloablative regimen; Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Use of Gonadotropin Releasing Hormone Agonist for Ovarian Preservation in SLE Patients on Cyclophosphamide
    Chu, Jun
    Fike, Alice
    Davis, Michael
    Manna, Zerai
    Ejaz, Komal
    Temesgen-Oyelakin, Yenealem
    Poncio, Elaine
    Ochoa, Isabel
    Decherney, Alan
    Hasni, Sarfaraz
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3583 - 3584
  • [32] GONADOTROPIN AND OVARIAN-STEROID PRODUCTION IN POLYCYSTIC OVARIAN SYNDROME DURING SUPPRESSION WITH A GONADOTROPIN-RELEASING HORMONE AGONIST
    TANBO, T
    ABYHOLM, T
    MAGNUS, O
    HENRIKSEN, T
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 28 (03) : 147 - 151
  • [33] Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
    Herzberger, Einat Haikin
    Knaneh, Sabaa
    Amir, Hadar
    Reches, Adi
    Ben-Yosef, Dalit
    Kalma, Yael
    Azem, Foad
    Samara, Nivin
    REPRODUCTIVE SCIENCES, 2021, 28 (12) : 3390 - 3396
  • [34] Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
    Einat Haikin Herzberger
    Sabaa Knaneh
    Hadar Amir
    Adi Reches
    Dalit Ben-Yosef
    Yael Kalma
    Foad Azem
    Nivin Samara
    Reproductive Sciences, 2021, 28 : 3390 - 3396
  • [35] Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation
    Ruxue Han
    Ziyi Song
    Huiling Li
    Chaohua Wang
    Leping Zhang
    Xin Yang
    Scientific Reports, 13
  • [36] Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation
    Han, Ruxue
    Song, Ziyi
    Li, Huiling
    Wang, Chaohua
    Zhang, Leping
    Yang, Xin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Chronic treatment with an agonist of gonadotropin-releasing hormone enhances luteal function in cattle
    Davis, TL
    Mussard, ML
    Jimenez-Severiano, H
    Enright, WJ
    Kinder, JE
    BIOLOGY OF REPRODUCTION, 2003, 69 (02) : 398 - 403
  • [38] Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion
    Toth, Michael J.
    Cooper, Brian C.
    Pratley, Richard E.
    Mari, Andrea
    Matthews, Dwight E.
    Casson, Peter R.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (06): : E1035 - E1045
  • [39] Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
    Kol, S
    FERTILITY AND STERILITY, 2004, 81 (01) : 1 - 5
  • [40] OVARIAN HYPERSTIMULATION FOR IN VITRO FERTILIZATION PRECEDED BY PROLONGED ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE AGONIST
    Tanbo, Tom
    Dale, Per Olav
    Abyholm, Thomas
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (04) : 333 - 337
12345